CVA Family Office’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Buy |
2,431
+79
| +3% | +$8.76K | 0.04% | 244 |
|
|
2025
Q1 | $264K | Buy |
2,352
+29
| +1% | +$3.25K | 0.04% | 238 |
|
|
2024
Q4 | $215K | Buy |
2,323
+760
| +49% | +$70.2K | 0.03% | 263 |
|
|
2024
Q3 | $131K | Buy |
1,563
+157
| +11% | +$13.2K | 0.02% | 325 |
|
|
2024
Q2 | $96.5K | Sell |
1,406
-175
| -11% | -$12K | 0.02% | 363 |
|
|
2024
Q1 | $116K | Sell |
1,581
-232
| -13% | -$17K | 0.02% | 335 |
|
|
2023
Q4 | $147K | Buy |
+1,813
| New | +$147K | 0.03% | 275 |
|
|
2023
Q3 | – | Sell |
-1,448
| Closed | -$112K | – | 519 |
|
|
2023
Q2 | $112K | Buy |
1,448
+60
| +4% | +$4.62K | 0.02% | 294 |
|
|
2023
Q1 | $115K | Sell |
1,388
-39
| -3% | -$3.24K | 0.03% | 285 |
|
|
2022
Q4 | $123K | Buy |
1,427
+85
| +6% | +$7.3K | 0.03% | 265 |
|
|
2022
Q3 | $83K | Buy |
1,342
+475
| +55% | +$29.4K | 0.02% | 268 |
|
|
2022
Q2 | $54K | Buy |
867
+845
| +3,841% | +$52.6K | 0.01% | 355 |
|
|
2022
Q1 | $1K | Sell |
22
-1,014
| -98% | -$46.1K | ﹤0.01% | 920 |
|
|
2021
Q4 | $75K | Sell |
1,036
-184
| -15% | -$13.3K | 0.02% | 290 |
|
|
2021
Q3 | $77K | Buy |
1,220
+99
| +9% | +$6.25K | 0.06% | 138 |
|
|
2021
Q2 | $77K | Buy |
1,121
+245
| +28% | +$16.8K | 0.02% | 285 |
|
|
2021
Q1 | $57K | Buy |
876
+355
| +68% | +$23.1K | 0.02% | 263 |
|
|
2020
Q4 | $30K | Sell |
521
-699
| -57% | -$40.3K | 0.02% | 237 |
|
|
2020
Q3 | $77K | Buy |
1,220
+100
| +9% | +$6.31K | 0.06% | 138 |
|
|
2020
Q2 | $86K | Buy |
1,120
+920
| +460% | +$70.6K | 0.07% | 124 |
|
|
2020
Q1 | $15K | Buy |
+200
| New | +$15K | 0.02% | 215 |
|